JPM JPMORGAN CHASE & CO

Price Chart

Executive Summary

Oppenheimer downgraded JPMorgan Chase (JPM) from Outperform to Perform on 2024-11-20, without a price target. This contrarian move comes amid a cluster of five analyst actions (Jefferies, CICC, Truist, Deutsche Bank). Oppenheimer has an 83% accuracy rate on 6 calls and the highest average return (14.2%) among firms covering JPM. Consensus is predominantly bullish: 19 Buy (incl. 3 Strong Buy) vs 13 Hold, no Sell. Price targets average $340.45, implying 8.7% upside from the current $313.23. EPS revisions are trending up (9 up vs 1 down for FY2026). However, insider selling is heavy (five executives sold on Apr 15, 2026, totaling ~$12.6M), and two large institutional holders (Two Sigma, Dodge & Cox) trimmed positions. Short interest ratio is elevated at 56.8% of off-exchange volume. The downgrade from a high-accuracy firm breaking from consensus is a bearish signal, especially given deteriorating insider and institutional sentiment.

Impact Score

Consensus & Targets

Full consensus: 3 Strong Buy, 16 Buy, 13 Hold, 0 Sell, 0 Strong Sell (32 analysts total). The majority (59%) rates JPM as Buy/Strong Buy, with 41% at Hold. No analysts recommend selling. Consensus direction is clearly bullish.

Mean target $340.45, median $338.00, high $391.00 (Barclays), low $288.00. Current price $313.23 implies 8.7% upside to the mean. Oppenheimer did not provide a price target, so its view is not directly comparable, but the absence of a target reinforces caution.

Recent Analyst Activity

30-day analyst activity: 0 upgrades, 0 downgrades, but recent actions show mainly maintains (Evercore, Truist, Piper Sandler) and two initiations (Jefferies Hold, CICC Outperform). EPS revision trend is positive: FY2026 EPS estimates had 9 upward revisions vs 1 downward in the past 30 days (current consensus $22.28). The current quarter (+1q) shows 4 up vs 3 down. Overall, estimates are being revised higher, which partially offsets the bearish analyst action.

Firm Track Record — Oppenheimer

Oppenheimer accuracy: 52% on 1809 calls | avg return: 3.6%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 14 firms with ≥5 scored calls.

Oppenheimer's JPM calls: 83% accurate (5 of 6), average return 14.2% — the highest among 14 firms tracked. For context, top performers include Wells Fargo (100% on 6 calls, +7%), Morgan Stanley (100% on 11, +8.2%), and RBC (100% on 3, +10.3%). The worst performers are Barclays (60% on 5, -0.2%) and Jefferies (50% on 2, +1.4%). Oppenheimer's high accuracy and outsized average return give this downgrade added weight.

Earnings Estimates

Next earnings: Jul 14, 2026

Cross-Platform Signals

Insider trading: Five C-suite executives sold on Apr 15, 2026 (totaling ~$12.6M), including Erdoes ($3.8M) and Piepszak ($2.8M). No insider buys recorded. Institutional activity: Two Sigma trimmed 46.4% ($138M), Dodge & Cox trimmed 36.1% (first trim) and later 27.3% (second). Norges Bank appears to have both a new position and an exit (likely data noise). Short interest: reported short volume ratio of 56.8% (short volume / total reported volume), suggesting elevated bearish positioning. The insider and institutional selling diverges from the bullish analyst consensus, converging with Oppenheimer's downgrade.

Documents Analyzed

Report based on filing metadata.

US Market Status